Peritoneal fluid | |||||||||||
Phase | rTregs (%) | P | eTregs (%) | P | nonTregs (%) | P | LAP+CD11b + Macrophages | P | TGF-β | P | |
Endometriosis | Proliferative (n = 12) | 0.73 ± 0.56 | ns | 3.9 ± 1.7 | ns | 7.7 ± 2.7 | ns | 13.0 ± 14.4 | ns | 1.12 ± 0.57 | ns |
Secretory (n = 16) | 0.82 ± 0.75 | 3.1 ± 2.8 | 6.0 ± 3.0 | 12.1 ± 16.4 | 1.09 ± 0.32 | ||||||
Control | Proliferative (n = 10) | 0.47 ± 0.60 | ns | 2.2 ± 1.5 | ns | 5.8 ± 2.1 | ns | 80.0 ± 19.7 | ns | 0.85 ± 0.26 | ns |
Secretory (n = 10) | 0.30 ± 0.24 | 1.8 ± 1.3 | 8.6 ± 1.6 | 81.3 ± 17.3 | 0.79 ± 0.26 | ||||||
Peripheral blood | |||||||||||
Phase | rTregs (%) | P | eTregs (%) | P | nonTregs (%) | P | LAP+CD11b + Monocytes | P | |||
Endometriosis | Proliferative (n = 12) | 1.3 ± 0.61 | ns | 1.2 ± 2.2 | ns | 2.4 ± 1.9 | ns | 83.5 ± 16.7 | ns | ||
Secretory (n = 16) | 2.1 ± 1.6 | 0.9 ± 1.0 | 3.0 ± 1.8 | 80.3 ± 19.7 | |||||||
Control | Proliferative (n = 10) | 1.3 ± 2.6 | ns | 1.2 ± 0.8 | ns | 4.4 ± 2.6 | ns | 79.2 ± 19.1 | ns | ||
Secretory (n = 10) | 0.8 ± 2.8 | 0.8 ± 0.4 | 3.9 ± 2.2 | 85.9 ± 11.5 |